publication venue for
- New targets for cancer chemotherapy.. 20. 2002
- Cyclin-dependent kinases as targets for cancer therapy. 2005
- DNA vaccines for melanoma. 2005
- Immunizing against partially defined antigen mixtures, gangliosides, or peptides to induce antibody, T cell, and clinical responses. 2005
- Lung cancer. 2005
- Cyclin-dependent kinases as targets for cancer therapy. 2003
- Lung cancer. 2003
- Immunotherapy of melanoma. 2002
- Update on the systemic treatment of lung cancer. 2002
- Lung cancer. 2001
- DNA topoisomerase II poisons and inhibitors. 1999
- DNA topoisomerase II poisons and inhibitors. 1997
- Monoclonal antibody therapy of cancer. 1997
- DNA topoisomerase inhibitors. 1996
- Monoclonal antibody therapy of cancer. 1996
- DNA topoisomerase inhibitors. 1994
- Monoclonal antibody therapy of cancer. 1994
- DNA topoisomerase inhibitors. 1993
- Monoclonal antibody therapy of cancer. 1993
- Monoclonal antibody therapy. 1992
- Monoclonal antibody therapy for cancer. 1991
- Biological effects and clinical applications of human colony-stimulating factors. 1990
- Monoclonal antibody therapy of cancer. 1990
- CT screening for lung cancer. 2002
- New anticancer agents. 1999